Nifurtimox
RxNorm 7421
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 7421 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Nifurtimox.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Nifurtimox
(Atom ID: 12252762)
PTPrescribable
Designated preferred name (PT):
Nifurtimox
(Atom ID: 241265)
FNPrescribable
Full form of descriptor (FN):
Nifurtimox (substance)
(Atom ID: 241270)
PTPrescribable
Designated preferred name (PT):
Nifurtimox-containing product
(Atom ID: 10807931)
FNPrescribable
Full form of descriptor (FN):
Product containing nifurtimox (medicinal product)
(Atom ID: 10308119)
Patient Education
Nifurtimox
Nifurtimox is used to treat Chagas disease (an infection caused by a parasite) in children from birth to 18 years old who weigh at least 5.5 pounds (2.5 kg). Nifurtimox is in a class of medications called antiprotozoals. It works by killing the organism that can cause Chagas disease.
[Learn More]
* Please review the disclaimer below.